Janus Henderson Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $209K | Hold |
39,469
| – | – | ﹤0.01% | 2305 |
|
2025
Q1 | $350K | Hold |
39,469
| – | – | ﹤0.01% | 2135 |
|
2024
Q4 | $541K | Hold |
39,469
| – | – | ﹤0.01% | 1996 |
|
2024
Q3 | $1.08M | Hold |
39,469
| – | – | ﹤0.01% | 1626 |
|
2024
Q2 | $965K | Sell |
39,469
-408
| -1% | -$9.97K | ﹤0.01% | 1638 |
|
2024
Q1 | $849K | Buy |
39,877
+1
| +0% | +$21 | ﹤0.01% | 1731 |
|
2023
Q4 | $763K | Sell |
39,876
-60
| -0.2% | -$1.15K | ﹤0.01% | 1783 |
|
2023
Q3 | $640K | Buy |
39,936
+6
| +0% | +$96 | ﹤0.01% | 1804 |
|
2023
Q2 | $925K | Sell |
39,930
-41
| -0.1% | -$950 | ﹤0.01% | 1648 |
|
2023
Q1 | $927K | Buy |
39,971
+24,682
| +161% | +$572K | ﹤0.01% | 1674 |
|
2022
Q4 | $222K | Sell |
15,289
-15,291
| -50% | -$222K | ﹤0.01% | 2139 |
|
2022
Q3 | $584K | Buy |
30,580
+15,305
| +100% | +$292K | ﹤0.01% | 1889 |
|
2022
Q2 | $278K | Sell |
15,275
-11
| -0.1% | -$200 | ﹤0.01% | 2123 |
|
2022
Q1 | $384K | Buy |
15,286
+13
| +0.1% | +$327 | ﹤0.01% | 2064 |
|
2021
Q4 | $422K | Buy |
15,273
+7,682
| +101% | +$212K | ﹤0.01% | 1998 |
|
2021
Q3 | $245K | Buy |
+7,591
| New | +$245K | ﹤0.01% | 1983 |
|